Pathology or Normal Variant: What Constitutes a Delay in Puberty?
Authors:
Open Access
- 7 July 2014
- journal article
- review article
- Published by S. Karger AG in Hormone Research in Paediatrics
- Vol. 82 (4) , 213-221
Abstract
Puberty is a complex maturation process that begins during fetal life and persists until the acquisition of reproduction function. The fundamental event that activates puberty occurs in the hypothalamus. A complex neuron network stimulates GnRH secretion, which stimulates pituitary gonadotropin secretion and then gonadal steroid secretion. Pubertal delay is defined as the presentation of clinical signs of puberty 2-2.5 SD later than in the normal population. Three major groups of etiopathogeneses are described: (1) hypogonadotropic hypogonadism, (2) hypergonadotropic hypogonadism, and (3) constitutional delay of puberty (CDP) - the most common cause of delayed puberty in boys. The differential diagnosis between CDP and isolated hypogonadotropic hypogonadism remains difficult. Mechanisms of pubertal timing are now better understood and genetic or epigenetic causes can explain some pubertal delays. However, there are still unexplained mechanisms. Treatment of delayed puberty is necessary to ensure full pubertal development for the adolescent and in case of hypogonadism, to restore fertility. Finally, precocious diagnosis of hypogonadism is primordial but can be difficult during childhood and in cases of partial hypogonadism. The study of genetic pubertal diseases or of different animal models could help to discover new diagnostic or therapeutic tools.Keywords
This publication has 60 references indexed in Scilit:
- Ataxia, Dementia, and Hypogonadotropism Caused by Disordered UbiquitinationNew England Journal of Medicine, 2013
- Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 Are Identified in Individuals with Congenital Hypogonadotropic HypogonadismThe American Journal of Human Genetics, 2013
- Evo-devo of human adolescence: beyond disease models of early pubertyBMC Medicine, 2013
- Genetic Overlap in Kallmann Syndrome, Combined Pituitary Hormone Deficiency, and Septo-Optic DysplasiaThe Journal of Clinical Endocrinology & Metabolism, 2012
- WDR11, a WD Protein that Interacts with Transcription Factor EMX1, Is Mutated in Idiopathic Hypogonadotropic Hypogonadism and Kallmann SyndromeThe American Journal of Human Genetics, 2010
- TAC3/TACR3 Mutations Reveal Preferential Activation of Gonadotropin-Releasing Hormone Release by Neurokinin B in Neonatal Life Followed by Reversal in AdulthoodThe Journal of Clinical Endocrinology & Metabolism, 2010
- GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadismProceedings of the National Academy of Sciences, 2009
- Association of the Timing of Puberty with a Chromosome 2 LocusThe Journal of Clinical Endocrinology & Metabolism, 2008
- Kallmann syndromeEuropean Journal of Human Genetics, 2008
- Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and miceJournal of Clinical Investigation, 2008